ORAI3 and pancreatic ductal adenocarcinoma: In pancreatic ductal adenocarcinoma, Orai3 knock-down resulted in decreased cell proliferation due to a halted cell cycle in the G2/M-phase [266]; however, the underlying mechanism for Orai3-dependent cell cycle regulation is unknown.